文献速递炎症性肠病

活动性克罗恩病患者组织学活动度、转录组和免疫组化分析的最佳活检部位评估

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-04-15

在三个中心前瞻性纳入51例结肠和/或回肠有直径>0.5 cm溃疡的克罗恩病患者,从最大溃疡边缘0 mm、7至8 mm和21至24 mm处活检,盲法评估组织学活动度、促炎基因表达和炎症细胞。溃疡边缘的组织学活动度评分(P < 0.0001)、促炎基因表达水平(P < 0.005)和髓过氧化物酶阳性细胞数(P < 0.0001)最高,随距离增加呈递减梯度(P < 0.05);结肠与回肠样本在任何位置所测参数均无差异。

要点

  • 溃疡边缘活检的组织学活动度评分、促炎基因mRNA水平和髓过氧化物酶阳性细胞数最高。
  • 组织学活动度、基因表达和髓过氧化物酶阳性细胞数随活检距离增加呈递减梯度(P < 0.05)。
  • 结肠与回肠样本在任何位置的所测参数均无差异。

核心结论

  • 克罗恩病患者溃疡边缘活检可获得最大的组织学疾病活动度和mRNA水平,且结肠与回肠读数相似。
  • 作者指出需进一步研究以在其他指标中确认此结论。

研究设计与样本

  • 前瞻性纳入51例结肠和/或回肠有直径>0.5 cm溃疡的克罗恩病患者,在三个中心进行。
  • 从最大溃疡边缘0 mm、7至8 mm和21至24 mm处获取活检。
  • 采用混合模型分析,以位置和肠段为固定效应、患者为随机效应,以考虑同一患者肠段间的相关性。

主要发现

  • 组织学疾病活动度评分在结肠和回肠的溃疡边缘活检中最高(P < 0.0001),随距离增加呈递减梯度(P < 0.05)。
  • 促炎基因表达水平在溃疡边缘最高(P < 0.005),随距离增加呈递减梯度(P < 0.05)。
  • 髓过氧化物酶阳性细胞数在溃疡边缘最高(P < 0.0001),随距离增加呈递减梯度(P < 0.05)。
  • 结肠与回肠样本在任何位置所测参数均无差异。

关键数值与推荐

  • 组织学活动度采用Global Histological Disease Activity Score、Robarts Histopathology和Nancy Histological指数盲法评估。
  • mRNA水平采用定量聚合酶链反应检测白介素-6、-8和-23(p19和p40亚基)、CD31和S100A9。
  • CD3+、CD68+和髓过氧化物酶阳性细胞数通过免疫组化定量。

局限性

  • 作者指出需进一步研究以在其他指标中确认此结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The appropriate location for biopsy procurement relative to an ulcer in active Crohn's disease is unknown. AIM: To explore the relationship between biopsy location, histological disease activity, proinflammatory gene expression and the presence of inflammatory cells. METHODS: Fifty-one patients with Crohn's disease and ulcers >0.5 cm diameter in the colon and/or ileum were prospectively enrolled at three centres. Biopsies were obtained from 0 mm, 7 to 8 mm and 21 to 24 mm from the edge of the largest ulcer. Histological activity was blindly assessed with the Global Histological Disease Activity Score, the Robarts Histopathology and Nancy Histological indices. Messenger ribonucleic acid (mRNA) levels for interleukins-6, -8 and -23 (p19 and p40 subunits), CD31 and S100A9 were measured using quantitative polymerase chain reaction. The number of CD3+, CD68+ and myeloperoxidase-positive cells was quantified by immunohistochemistry. Data were analysed using mixed models with location and segment as fixed effects and patients as random effect to account for correlation among segments within a patient. RESULTS: Histological disease activity scores (P < 0.0001), proinflammatory gene expression levels (P < 0.005) and numbers of myeloperoxidase-positive cells (P < 0.0001) were highest in biopsies from the ulcer edge in the colon and ileum, with decreasing gradients observed with distance from the edge (P < 0.05). No differences between colonic and ileal samples were detected for the parameters measured at any location. CONCLUSIONS: Biopsies from the ulcer edge in patients with Crohn's disease yielded the greatest histological disease activity and mRNA levels and had similar readouts in the colon and ileum. Research is needed to confirm this conclusion for other measures.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Novak G, Stevens T, Van Viegen T, et al. Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease. Aliment Pharmacol Ther. 2019. PMID: 30983024. doi:10.1111/apt.15250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。